logo
Select company
Select metric
$ -138.98MEarnings Before Interest Taxes & Depreciation Amortization (EBITDA)
VS
Market
6
Sector
13
Industry
19
History
-
$ 9.03Close
$ 1.1 - $ 9.52 52-Week Range
Ticker Information

Ticker

TNGX

Company Name

TANGO THERAPEUTICS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

TANGO THERAPEUTICS INC - Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

TNGX - EBITDA Historical data
DateDepreciation, Amortization & AccretionEarning Before Interest & Taxes (EBIT)Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)
6/30/2025$ 6.41M$ -145.39M$ -138.98M
3/31/2025$ 6.33M$ -132.06M$ -125.73M
12/31/2024$ 6.24M$ -130.09M$ -123.85M
9/30/2024$ 6.2M$ -123.19M$ -116.99M
6/30/2024$ 6.16M$ -116.32M$ -110.15M
3/31/2024$ 6.11M$ -111.48M$ -105.36M
12/31/2023$ 6.02M$ -101.61M$ -95.59M
9/30/2023$ 5.94M$ -99.9M$ -93.96M
6/30/2023$ 5.64M$ -106.71M$ -101.08M
3/31/2023$ 4.82M$ -110.92M$ -106.11M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • TANGO THERAPEUTICS INC's latest trailing twelve months (TTM) EBITDA stands at $ -116.18K.
  • Over the past 5 years, TANGO THERAPEUTICS INC's average EBITDA has been $ -94.06M.
  • The median EBITDA for TANGO THERAPEUTICS INC during this period was $ -101.08M
  • TANGO THERAPEUTICS INC reached its highest EBITDA over the past 5 years at $ -116.18K.
  • The lowest EBITDA recorded by TANGO THERAPEUTICS INC in the same timeframe $ -138.98M

TANGO THERAPEUTICS INC's EBITDA vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

EBITDA Benchmarks
CompanyEBITDA
VIR : VIR BIOTECHNOLOGY INC $ -533.7MQURE : UNIQURE NV $ -119.56MNUVB : NUVATION BIO INC $ -200.93MAUTL : AUTOLUS THERAPEUTICS PLC $ -227.48MABUS : ARBUTUS BIOPHARMA CORP $ -53.13MZBIO : ZENAS BIOPHARMA INC $ -175.83MBCYC : BICYCLE THERAPEUTICS PLC $ -240.81MALMS : ALUMIS INC $ -232.06MFHTX : FOGHORN THERAPEUTICS INC $ -66.44MIMNM : IMMUNOME INC $ -209.77M

Similar metrics to EBITDA:

Definition of Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

[Calculation] EBITDA is a non-GAAP accounting metric that lets investors asses profitability net of expenses dependent on financing decision, tax strategy and depreciation schedules. It is calculated by adding depreciation and amortisation expenses [DepAmor] back to [EBIT].
EBIT + DepAmor
(=) EBITDA EBITDA for TANGO THERAPEUTICS INC is calculated as follows: EBIT [ $ -116.18K ] + DepAmor [ $ 0 ]
(=) EBITDA [ $ -116.18K ]

TNGX - Earnings Before Interest Taxes & Depreciation Amortization (EBITDA), Last 5 years

$ -138.98M

Minimum

Jun 30, 2025

$ -116.18K

Maximum

Dec 31, 2020

$ -94.06M

Average

$ -101.08M

Median

EBITDA Benchmark Analysis

 The chart above depicts the distribution of EBITDA for companies in the Total Stock Market. The average EBITDA of the companies is $ 58.79M with a standard deviation of $ 166.94M.
The following table provides additional summary stats:
EBITDA in the Market:
filtered constituents3.25K
min$ -493.3M
max$ 590.6M
average$ 58.79M
median$ 8.83M
std$ 166.94M